![](/static/253f0d9b/assets/icons/icon-96x96.png)
![](https://lemmy.team/api/v3/image_proxy?url=https%3A%2F%2Fbeehaw.org%2Fpictrs%2Fimage%2F3f6f8c7f-8f4e-48a6-b56f-748fb4d05eb0.png)
Before being an appetite suppressant, it is a medication for diabetes.
The problem is not the margin Novo Nordisk makes on an appetite suppressant, contrary to what the headline says.
The twofold problem is the margin on a diabetes drug, which weighs heavily on patients and health insurers around the world. And the potential supply problems for diabetics, when a vital drug is sold as a miracle weight-loss remedy.
To take things a step further, the only smart male on board is an orange cat.